Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Col-DM Study
NCT07837934Phase 2Recruiting
- Sponsor
- Tan Tock Seng Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in atherosclerosis, cardiovascular disease (CVD), sponsored by Tan Tock Seng Hospital. Started Jul 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
atherosclerosiscardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT07837934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837934.